Literature DB >> 1467583

Lewy body disease.

L A Hansen1, D Galasko.   

Abstract

Subsumed under the rubric of Lewy body disease are idiopathic Parkinson's disease (PD), pure diffuse Lewy body disease (DLBD), and, most commonly, combined brainstem and neocortical Lewy bodies with Alzheimer's disease (AD) pathology in a relatively early developmental stage. Clinical correlates are dementia with psychiatric and subcortical features plus mild extrapyramidal signs (EPS).

Entities:  

Mesh：

Year:  1992        PMID： 1467583

Source DB:  PubMed          Journal:  Curr Opin Neurol Neurosurg        ISSN： 0951-7383


  9 in total

1.  Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study.

Authors:  T A Ala; K H Yang; J H Sung; W H Frey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

Review 2.  Management of neurological disorders: dementia.

Authors:  M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

3.  Transcranial magnetic stimulation studies in the Miller Fisher syndrome: evidence of corticospinal tract abnormality.

Authors:  Y L Lo; P Ratnagopal
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

Review 4.  Diffuse Lewy body disease: clinical, pathological, and neuropsychological review.

Authors:  C A Luis; W Mittenberg; C S Gass; R Duara
Journal:  Neuropsychol Rev       Date:  1999-09       Impact factor: 7.444

Review 5.  Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy.

Authors:  Jasmohan S Bajaj; Angela Gentili; James B Wade; Michael Godschalk
Journal:  Clin Gastroenterol Hepatol       Date:  2022-08       Impact factor: 13.576

6.  Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.

Authors:  Brian Spencer; Rewati Potkar; Margarita Trejo; Edward Rockenstein; Christina Patrick; Ryan Gindi; Anthony Adame; Tony Wyss-Coray; Eliezer Masliah
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

7.  Spectrum of neurocognitive dysfunction in Indian population on FDG PET/CT imaging.

Authors:  Rajnish Sharma; Madhavi Tripathi; Maria M D'Souza; Abhinav Jaimini; Raunak Varshney; Puja Panwar; Aruna Kaushik; Sanjeev Saw; Romana Seher; Santosh Pandey; Dinesh Singh; Yachna Solanki; Anil K Mishra; Anupam Mondal; Rp Tripathi
Journal:  Indian J Nucl Med       Date:  2011-04

8.  Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET).

Authors:  Siroos Mirzaei; Peter Knoll; Horst Koehn; Thomas Bruecke
Journal:  BMC Nucl Med       Date:  2003-02-20

Review 9.  Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.

Authors:  Masayo Fujita; Gilbert Ho; Yoshiki Takamatsu; Ryoko Wada; Kazutaka Ikeda; Makoto Hashimoto
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.